Emerging research suggest this peptide, a dual activator targeting both GLP-1 and another hormone, could represent a notable development for weight loss . Preliminary patient trials have indicated impressive decreases in body fat , potentially exceeding other obesity medications . Despite this, more study is needed to thoroughly understand its sust